Kolon Pharma

South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...

Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...

South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...

Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...

ATTOMAX golf balls approved by the World Record Committee (WRC) as the longest-flying golf balls in the world finally hit the South Korean market on...

Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...

South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...

Kolon Industries Inc., a Korean manufacturer of chemical and textile products, announced on Monday that it has become the first company in the domes...

JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...

South Korean fuel cell manufacturer Doosan Fuel Cell, and Kolon Global Corp., a South Korean company that specializes in the production of industria...

South Korea's Kolon Group announced on Wednesday that Kolon DACC Composite participated in the launch of the first private test launch vehicle in Ko...

Kolon Industries Inc.'s Future Technology Institute announced on Wednesday that it has partnered with Stora Enso Oyj, a global biomaterials leader f...

Kolon Industries Inc., a Korean manufacturer of chemical and textile products, said on Wednesday that it was exhibiting its hydrogen fuel cell parts...

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...

Kolon Plastics Inc. said on Tuesday that it has signed an agreement with Netspa, a South Korean recycling social venture, to jointly develop enginee...

Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...

South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...

South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...

Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...

South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...

Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...

South Korea’s Hyosung Group and its longtime rival Kolon Group in the fiber, textile and petrochemical businesses are poised to give up their ...

CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, said on Monday that it is moving into the pet nutrition supplement market by acquirin...

South Korea's construction engineering company Kolon Global Corp. said on Monday that it has obtained a technology patent for the multi-purpose syst...

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

South Korea's Kolon Mobility Group has been launched with Lee Kyu-ho, the great grandson of the Kolon Group founder Lee Won-man, as co-CEO. Formerly...

South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...

South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...